Simone Greven
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Glycosylation and Glycoproteins Research 5
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 2
- Protein purification and stability 2
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Axel Harrenga (2 shared papers)Christoph Mahlert (11 shared papers)Nils Griebenow (5 shared papers)Stefan Bräse (2 shared papers)Peter Bringmann (1 shared paper)Beatrix Stelte‐Ludwig (10 shared papers)Hans‐Georg Lerchen (10 shared papers)Dorian Immler (1 shared paper)
- Journals
- Cancer Research (3 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Bioconjugate Chemistry (2 papers)Chemistry - A European Journal (1 paper)Cancers (1 paper)
- Partner nations
- GermanySwitzerlandFrance
In The Last Decade
Simone Greven
17 papers receiving 220 citations
Peers
Comparison fields: 5 of 38
- Radiology, Nuclear Medicine and Imaging 113
- Oncology 100
- Molecular Biology 147
- Organic Chemistry 52
- Immunology and Allergy 11
Countries citing papers authored by Simone Greven
This map shows the geographic impact of Simone Greven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Greven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Greven more than expected).
Fields of papers citing papers by Simone Greven
This network shows the impact of papers produced by Simone Greven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Greven. The network helps show where Simone Greven may publish in the future.
Co-authors
The 25 scholars most cited alongside Simone Greven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 51 | |
| 2 | 2016 | 32 | |
| 3 | 2011 | 28 | |
| 4 | 2018 | 25 | |
| 5 | 2006 | 19 | |
| 6 | 2020 | 15 | |
| 7 | 2019 | 14 | |
| 8 | 2023 | 10 | |
| 9 | 2015 | 10 | |
| 10 | 2020 | 10 | |
| 11 | 2023 | 8 | |
| 12 | 2018 | 2 | |
| 13 | 2019 | 2 | |
| 14 | 2019 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2014 | 1 | |
| 17 | 2019 | 1 |
About Simone Greven
Simone Greven is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Cell Biology and Spectroscopy, having authored 17 papers that have together received 230 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers), Peptidase Inhibition and Analysis (5 papers), HER2/EGFR in Cancer Research (4 papers), Ubiquitin and proteasome pathways (4 papers), Microtubule and mitosis dynamics (3 papers), Protein Degradation and Inhibitors (2 papers) and Protein purification and stability (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (113 citations), Oncology (100 citations), Molecular Biology (147 citations), Organic Chemistry (52 citations) and Immunology and Allergy (11 citations). Simone Greven has collaborated with scholars based in Germany, Switzerland and France. Frequent co-authors include Axel Harrenga, Christoph Mahlert, Nils Griebenow, Stefan Bräse, Peter Bringmann, Beatrix Stelte‐Ludwig, Hans‐Georg Lerchen, Dorian Immler, Peter Reinemer and Anette Sommer. Their work appears in journals such as Cancer Research, European Journal of Pharmaceutics and Biopharmaceutics, Bioconjugate Chemistry, Chemistry - A European Journal and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.